136 related articles for article (PubMed ID: 6415365)
1. Long-term post-menopausal hormone therapy and serum HDL-C, total cholesterol and triglycerides.
Vilska S; Punnonen R; Rauramo L
Maturitas; 1983 Aug; 5(2):97-104. PubMed ID: 6415365
[TBL] [Abstract][Full Text] [Related]
2. Skinfold thickness and long-term post-menopausal hormone therapy.
Punnonen R; Vilska S; Rauramo L
Maturitas; 1984 Apr; 5(4):259-62. PubMed ID: 6738372
[TBL] [Abstract][Full Text] [Related]
3. Effects of oestradiol valerate plus two different progestogens on serum lipids during post-menopausal replacement therapy.
Makkonen M; Saarikoski S; Penttilä I
Maturitas; 1991 Dec; 14(1):43-8. PubMed ID: 1791771
[TBL] [Abstract][Full Text] [Related]
4. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
Paterson ME; Sturdee DW; Moore B; Whitehead TP
Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948
[TBL] [Abstract][Full Text] [Related]
5. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
Hirvonen E; Lipasti A; Mälkönen M; Kärkkäinen J; Nuntila J; Timonen H; Manninen V
Maturitas; 1987 Apr; 9(1):69-79. PubMed ID: 2955205
[TBL] [Abstract][Full Text] [Related]
6. Serum lipids during oestradiol-valerate/norgestrel treatment of menopausal women. Double-blind study of a sequential preparation.
Christensen NC; Davidsen PC; Secher NJ; Pedersen GT
Acta Obstet Gynecol Scand; 1975; 54(3):213-6. PubMed ID: 1099859
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum lipids during treatment with norgestrel, oestradiol-valerate and cycloprogynon.
Nielsen FH; Honoré E; Kristoffersen K; Secher NJ; Pedersen GT
Acta Obstet Gynecol Scand; 1977; 56(4):367-70. PubMed ID: 602705
[TBL] [Abstract][Full Text] [Related]
8. Serum oestrone, oestradiol and oestriol concentrations during oral oestradiol valerate and oestriol succinate therapy in ovariectomized women.
Rauramo L; Punnonen R; Grönroos M
Maturitas; 1978 Sep; 1(2):79-85. PubMed ID: 755960
[TBL] [Abstract][Full Text] [Related]
9. Low-risk lipoprotein pattern in post-menopausal women on sequential oestrogen/progestogen treatment.
Christiansen C; Christensen MS; Grande P; Transbøl I
Maturitas; 1984 Mar; 5(3):193-9. PubMed ID: 6727693
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
Nash AL; Cornish EJ; Hain R
Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the metabolic tolerance in postmenopausal women over a 1-year period of two hormone replacement therapies containing estradiol in combination with either norgestrel or trimegestone.
Meuwissen JH; Beijers-De Bie L; Vihtamaki T; Tuimala R; Siseles N; Magaril C; The HS; Houben PW; Murga M; Spielmann D; De Villiers TJ
Gynecol Endocrinol; 2002 Apr; 16(2):155-62. PubMed ID: 12012627
[TBL] [Abstract][Full Text] [Related]
12. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
Jensen J; Riis BJ; Strøm V; Christiansen C
Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
[TBL] [Abstract][Full Text] [Related]
13. Effect of orally administered oestrogens on circulating oestrogen profiles in post-menopausal women.
Aedo AR; Sundén M; Landgren BM; Diczfalusy E
Maturitas; 1989 Jun; 11(2):159-68. PubMed ID: 2547139
[TBL] [Abstract][Full Text] [Related]
14. Effect of oestriol succinate on serum lipids.
Saarikoski S; Niemelä A; Jokela H; Pystynen P
Maturitas; 1981 Dec; 3(3-4):235-9. PubMed ID: 7334934
[TBL] [Abstract][Full Text] [Related]
15. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
Jensen J; Christiansen C
Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments.
Rauramo L; Punnonen R; Grönroos M
Maturitas; 1981 Aug; 3(2):183-6. PubMed ID: 7289888
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
Fåhraeus L; Larsson-Cohn U; Wallentin L
Acta Endocrinol (Copenh); 1982 Dec; 101(4):597-602. PubMed ID: 7158232
[TBL] [Abstract][Full Text] [Related]
18. Changes in lipoproteins and subfractions following oophorectomy and oestrogen replacement in peri-menopausal women.
Blumenfeld Z; Aviram M; Brook GJ; Brandes JM
Maturitas; 1983 Aug; 5(2):77-83. PubMed ID: 6579340
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and biotransformation of orally administered oestrone sulphate and oestradiol valerate in post-menopausal women.
Aedo AR; Landgren BM; Diczfalusy E
Maturitas; 1990 Nov; 12(4):333-43. PubMed ID: 2124648
[TBL] [Abstract][Full Text] [Related]
20. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
